Navigation Links
Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis

amyloid formation and represents a truly novel strategy for treating nephropathy associated with AA amyloidosis," she concluded.

    Findings about eprodisate (KIACTA(TM)) reported in the article include:


    - At the end of the 24-month period, the disease had worsened in 24 of

      89 patients assigned to eprodisate (KIACTA(TM)) (27%), and 38 of

      94 patients given placebo (40%, p=0.06)(1).

    - Eprodisate (KIACTA(TM)) decreased the risk of the primary endpoint, a

      composite of worsening of renal function or death, by 42%

      (HR 0.58, p=0.02)(2).

    - Eprodisate (KIACTA(TM)) significantly reduced the risk of the doubling

      of serum creatinine, the risk of 50% reduction in creatinine clearance

      and the slope of decline in creatinine clearance.

    - Eprodisate (KIACTA(TM)) treatment was associated with a reduction in

      the risk of developing end-stage renal disease, one of the clinical

      measures of the composite primary endpoint that was not statistically

      significant at the two-year time point.

    - There was no significant difference between the two groups in the risk

      of death.

    - Eprodisate (KIACTA(TM)) did not affect proteinuria, amyloid content in

      abdominal fat and, as expected, did not change the blood level of serum

      amyloid A protein.

    - The frequency and types of adverse events and death were similar in the

      treated and placebo groups. The most frequent adverse events (as

      categorized by common terms) were diarrhea, headaches and nausea.


    About Eprodisate (KIACTA(TM))

Eprodisate (KIACTA(TM)) was investigated in a landmark international, randomized, double-blind, placebo-controlled, and parallel-designed clinical trial in which 183 AA amyloidosis patients were enrolled at 27 sites around the world. Patients who completed the clinical trial were eligible for enrollment in an ongoing open-label extension study, some of whom have now been re
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
2. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
3. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
4. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
5. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
6. Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
7. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
8. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
9. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
10. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
11. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
Post Your Comments:
(Date:7/10/2014)... -- Integrated Silicon Solution, Inc. (Nasdaq: ISSI ... solutions, today announced that it will host its earnings ... a.m. Pacific Time (10:00 a.m. Eastern Time) to discuss ... quarter ended June 30, 2014. To access ... a.m. Pacific time on July 24, 2014.  The participant ...
(Date:7/10/2014)... , July 10, 2014  BC Technical, the largest ... MiE America , Inc., a leading provider of Siemens ... a long-term agreement naming BC Technical as the authorized ... MiE and BC Technical announced today that ... establish BC Technical as the service and systems provider ...
(Date:7/10/2014)... July 10, 2014  Decision Resources Group finds ... disease (ID) specialists are willing to prescribe Durata,s ... for use as OPAT, approximately two-thirds of the ... to their hospital inpatients. However, our findings indicate ... are initiated on OPAT following hospital discharge, and ...
Breaking Medicine Technology:BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3
(Date:7/11/2014)... FRIDAY, July 11, 2014 (HealthDay News) -- Children ... greater risk for complications and potentially even death ... a new study. However, the Johns Hopkins ... "miniscule." The researchers analyzed data on nearly ... United States underwent over a 22-year period. ...
(Date:7/11/2014)... July 11, 2014 According to a ... Application Market by Communication Technology (ZigBee, Z-Wave, Bluetooth, Wi-Fi, ... Industrial, Automotive & Transportation, Agriculture) & Geography - Global ... of Internet of Things market was worth $1029.5 Billion ... by 2020, at an estimated CAGR of 4.08% from ...
(Date:7/11/2014)... -- Researchers from The Miriam Hospital have found ... have significantly higher rates of smoking than those ... were less likely to attempt quitting than those ... not be sufficient for this population. The study ... of print in the American Journal of ...
(Date:7/11/2014)... Steven Reinberg HealthDay Reporter ... to protect children from the worldwide scourge of dengue fever ... While the vaccine only prevented dengue fever in 56 percent ... three shots, it protected more than 88 percent of them ... lead to hospitalization, and sometimes death. "This vaccine has ...
(Date:7/11/2014)... Last month Watkins Insurance Group introduced ... the agency as a specialist in insurance and bonding ... Bachelor’s Degree in Business Administration from Texas State University. ... manage everything from performance and payment bonds, license and ... needs for those in the asphalt supplier industry. In ...
Breaking Medicine News(10 mins):Health News:Emergency Surgeries on Weekends Riskier for Kids: Study 2Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Miriam Hospital study examines smoking prevalence 2Health News:Dengue Fever Vaccine Shows Some Promise in Trial 2Health News:Dengue Fever Vaccine Shows Some Promise in Trial 3
... Office-based, surgeon-performed, ultrasound-guided, fine needle aspiration (FNA) of head ... rate compared to the standard palpation technique, indicates new ... Head and Neck Surgery . FNA ... or masses. In this technique, a thin, hollow needle ...
... Spanish researchers determined that rats treated with recombinant ghrelin displayed ... reduced the amount of fibrogenic cells by 25% in the ... liver damage and reduced oxidative stress and inflammation in the ... the March issue of Hepatology , a journal of ...
... ... ... ... ...
... Survey ... ... an estimated 12 million Americans, yet according to a survey of 1,000 people conducted by ... and saw the benefits of undergoing genetic testing, close to 80 percent had never talked ...
... finds , SUNDAY, Feb. 28 (HealthDay News) -- Exposure to ... of developing asthma, researchers say. , "In an earlier study, ... endotoxin and allergens [mite and cockroach] in their day-care centers. ... cohort study, if infants from low-income families with high risk ...
... ... ... ... ...
Cached Medicine News:Health News:Office-based ultrasound-guided FNA superior in diagnosing head and neck lesions 2Health News:Ghrelin mitigates liver fibrosis in animal models; regulates human fibrosis 2Health News:Ghrelin mitigates liver fibrosis in animal models; regulates human fibrosis 3Health News:Multiple Medalist Kristina Groves Matches Hain Celestial's $5,000 Donation to Right to Play 2Health News:Multiple Medalist Kristina Groves Matches Hain Celestial's $5,000 Donation to Right to Play 3Health News:Multiple Medalist Kristina Groves Matches Hain Celestial's $5,000 Donation to Right to Play 4Health News:Multiple Medalist Kristina Groves Matches Hain Celestial's $5,000 Donation to Right to Play 5Health News:Multiple Medalist Kristina Groves Matches Hain Celestial's $5,000 Donation to Right to Play 6Health News:Multiple Medalist Kristina Groves Matches Hain Celestial's $5,000 Donation to Right to Play 7Health News:Multiple Medalist Kristina Groves Matches Hain Celestial's $5,000 Donation to Right to Play 8Health News:Genetic Disease Foundation Encourages Americans to Know Their Genes at KnowYourGenes.org in Observance of World Rare Disease Day 2Health News:Genetic Disease Foundation Encourages Americans to Know Their Genes at KnowYourGenes.org in Observance of World Rare Disease Day 3Health News:Genetic Disease Foundation Encourages Americans to Know Their Genes at KnowYourGenes.org in Observance of World Rare Disease Day 4Health News:Household Dirt Won't Raise Asthma Risk in Infants 2Health News:CareTech Solutions Honors Five Hospitals with Rising Star Awards 2Health News:CareTech Solutions Honors Five Hospitals with Rising Star Awards 3Health News:CareTech Solutions Honors Five Hospitals with Rising Star Awards 4Health News:CareTech Solutions Honors Five Hospitals with Rising Star Awards 5
The MACS VA_500 (variable atmosphere) is primarily for the study and isolation of microaerophilic organisms,including Campylobacter spp,Helicobacter pylori and other similarly fastdious organisms....
Lose the variability of anaerobic jars and step into the 21st century with the anaerobic workstation that provides the answer to the common problems associated with anaerobic microbiology....
... is the most versatile orthopedic/trauma ... designed for both lower body ... an integrated shoulder attachment. The ... operating table for your most ...
... With MARS, the operating theatre is ready for ... surgical fields. Its modern design allows a quick, ... The individual components are connected securely and sturdily ... system. And if there should ever be a ...
Medicine Products: